Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor

Breast Cancer Research and Treatment

Volumn 135, Issue 2, 2012, Pages 495-503

  Kona, Fathima R ^a   Stark, Karri ^a   Bisoski, Luke ^a   Buac, Daniela ^a   Cui, Qiuzhi ^a   Dou, Q Ping ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Breast cancer; Breast cancer associated gene 2 (BCA2); Estrogen (E2); Estrogen receptor (ER); Estrogen response element (ERE); Tamoxifen and ICI 182 178 (ICI)

Indexed keywords

BRCA2 PROTEIN; CYCLOHEXIMIDE; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; SMALL INTERFERING RNA; TAMOXIFEN;

ANIMAL CELL; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOPLASM; ESTROGEN RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; UPREGULATION; WESTERN BLOTTING;

BREAST NEOPLASMS; CHROMATIN IMMUNOPRECIPITATION; CYCLOHEXIMIDE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HUMANS; LUCIFERASES, RENILLA; MCF-7 CELLS; PROTEIN BINDING; PROTEIN SYNTHESIS INHIBITORS; RESPONSE ELEMENTS; RNA INTERFERENCE; TRANSCRIPTIONAL ACTIVATION; UBIQUITIN-PROTEIN LIGASES;

EID: 84866547009     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2107-4     Document Type: Article

References (42)

1. Jemal A et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277-300. doi:10.10.3322/caac.20073
2. Gruvberger S et al (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61(16):5979-5984 (Pubitemid 32762524)
3. Oh DS et al (2006) Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. J Clin Oncol 24(11): 1656-1664. doi:10.1200/JCO.2005.03.2755 (Pubitemid 46622136)
4. Sorlie T et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Nat Acad Sci USA 98(19):10869-10874 (Pubitemid 32878711)
5. Dubik D, Dembinski TC, Shiu RP (1987) Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res 47(24 Pt 1): 6517-6521 (Pubitemid 18019647)
6. Lang JC et al (1988) Transcriptional regulation of the human c-myc gene. Br J Cancer Suppl 9:62-66 (Pubitemid 19054742)
7. Altucci L et al (1996) 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 12(11):2315-2324 (Pubitemid 26192711)
8. Prall OW et al (1998) c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol 18(8):4499-4508 (Pubitemid 28343034)
9. Seth P et al (2002) Novel estrogen and tamoxifen induced genes identified by SAGE (serial analysis of gene expression). Oncogene 21(5):836-843 (Pubitemid 34146295)
10. Hall JM, Couse JF, Korach KS (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276(40):36869-36872
11. Sanchez R et al (2002) Diversity in the mechanisms of gene regulation by estrogen receptors. BioEssays 24(3):244-254 (Pubitemid 34248690)
12. McKenna NJ, O'MalleyBW(2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108(4): 465-474 (Pubitemid 34260872)
13. Katzenellenbogen BS et al (2000) Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55:163-193 discussion 194-195
14. Klinge CM (2001) Estrogen receptor interaction with estrogen response elements. Nucl Acids Res 29(14):2905-2919 (Pubitemid 32685217)
15. Kushner PJ et al (2000) Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp 230: 20-26 discussion 27-40
16. Carroll JS et al (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38(11):1289-1297 (Pubitemid 44646291)
17. Burger AM et al (2010) Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer. Open Cancer J 3(1):116-123
18. Burger AM et al (2005) A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer Res 65(22):10401-10412 (Pubitemid 41743734)
19. Cavailles V, Garcia M, Rochefort H (1989) Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol 3(3):552-558 (Pubitemid 19085054)
20. Glass CK (1994) Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15(3):391-407 (Pubitemid 24180795)
21. Kato S et al (1992) A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 50-TGACC-30 motifs acting synergistically. Cell 68(4):731-742
22. O'Lone R et al (2004) Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18(8):1859-1875 (Pubitemid 39022608)
23. Aumais JP et al (1996) Function of directly repeated half-sites as response elements for steroid hormone receptors. J Biol Chem 271(21):12568-12577 (Pubitemid 26160931)
24. Walker P et al (1984) Sequence homologies in the region preceding the transcription initiation site of the liver estrogenresponsive vitellogenin and apo-VLDLII genes. Nucl Acids Res 12(22):8611-8626
25. El Marzouk S et al (2008) The plasticity of estrogen receptor-DNA complexes: binding affinity and specificity of estrogen receptors to estrogen response element half-sites separated by variant spacers. J Steroid Biochem Mol Biol 110(1-2):186-195
26. Ellerman JE et al (2007) Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13(10):2836-2848 (Pubitemid 46850704)
27. Klinge CM et al (1992) Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro. Cancer Res 52(5):1073-1081
28. Ludwig LB et al (1990) A microtiter well assay for quantitative measurement of estrogen receptor binding to estrogen-responsive elements. Mol Endocrinol 4(7):1027-1033
29. Klinge CM et al (1998) Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Mol Cell Endocrinol 143(1-2):79-90 (Pubitemid 28458744)
30. Furlow JD, Murdoch FE, Gorski J (1993) High affinity binding of the estrogen receptor to a DNA response element does not require homodimer formation or estrogen. J Biol Chem 268(17): 12519-12525 (Pubitemid 23182410)
31. Zhang Z, Teng CT (2000) Estrogen receptor-related receptor alpha 1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J Biol Chem 275(27):20837-20846 (Pubitemid 30457677)
32. Anderson I, Gorski J (2000) Estrogen receptor alpha interaction with estrogen response element half-sites from the rat prolactin gene. Biochemistry 39(13):3842-3847 (Pubitemid 30183867)
33. Kim J et al (2000) Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 74(4):157-168 (Pubitemid 32121651)
34. Balleine RL, Clarke CL (1999) Expression of the oestrogen responsive protein pS2 in human breast cancer. Histol Histopathol 14(2):571-578 (Pubitemid 29159026)
35. Lee YJ, Gorski J (1996) Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy. Proc Nat Acad Sci USA 93(26):15180-15184 (Pubitemid 27009573)
36. Kaneko KJ, Gelinas C, Gorski J (1993) Activation of the silent progesterone receptor gene by ectopic expression of estrogen receptors in a rat fibroblast cell line. Biochemistry 32(32): 8348-8359 (Pubitemid 23265828)
37. Petz LN, Nardulli AM (2000) Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol Endocrinol 14(7):972-985 (Pubitemid 32250515)
38. Tyulmenkov VV, Klinge CM (2001) Estrogen receptors alpha and beta exhibit different estradiol and estrogen response element binding in the presence of nonspecific DNA. Arch Biochem Biophys 390(2):253-264 (Pubitemid 32568487)
39. Porter W et al (1997) Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11(11):1569-1580 (Pubitemid 27435406)
40. Lin CY et al (2007) Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 3(6):e87
41. Jordan VC (1995) Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer. Annu Rev Pharmacol Toxicol 35:195-211
42. Jordan VC (1995) Third annual William L. McGuire Memorial Lecture. ''Studies on the estrogen receptor in breast cancer''-20 years as a target for the treatment and prevention of cancer. Breast Cancer Res Treat 36(3):267-285